Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatocyte growth factor may contribute to male protection against pulmonary arterial hypertension.

Biology of sex differences·2026
Same author

Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement.

American journal of respiratory and critical care medicine·2025
Same author

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Circulation·2025
Same author

Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure.

International journal of molecular sciences·2025
Same author

Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Intestinal IFNα4 promotes 15-HETE diet-induced pulmonary hypertension.

Respiratory research·2024

Related Experiment Video

Updated: Jul 19, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Heart hypertrophy during pregnancy: a better functioning heart?

Mansoureh Eghbali1, Yibin Wang, Ligia Toro

  • 1Department of Anesthesiology, Division of Molecular Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA 90095-7115, USA.

Trends in Cardiovascular Medicine
|October 24, 2006
PubMed
Summary

Pregnancy induces cardiac changes in women, including hypertrophy and diastolic dysfunction. Research reveals specific molecular mechanisms, like Kv4.3 channel downregulation, contributing to these adaptations.

More Related Videos

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Related Experiment Videos

Last Updated: Jul 19, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Area of Science:

  • Cardiovascular Physiology
  • Reproductive Endocrinology
  • Molecular Cardiology

Background:

  • Healthy pregnancies induce physiological cardiac adaptations, including ventricular hypertrophy and diastolic dysfunction, due to increased demands.
  • Electrocardiogram changes, such as prolonged QT-interval dispersion, are observed during pregnancy.
  • Molecular mechanisms and the role of sex hormones in pregnancy-related cardiac changes were previously underexplored.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cardiac hypertrophy during pregnancy.
  • To explore the role of sex hormones in pregnancy-induced cardiac adaptations.
  • To identify molecular differences between pregnancy-related and pathological cardiac hypertrophy.

Main Methods:

  • Utilized mouse and rat models to study cardiac molecular signatures during pregnancy.
  • Analyzed gene expression markers associated with cardiac hypertrophy.
  • Investigated the expression of the Kv4.3 channel and the activity of c-Src kinase.

Main Results:

  • Pregnancy-related cardiac hypertrophy exhibits a distinct molecular signature compared to pathological hypertrophy, with classic gene markers remaining unchanged.
  • Both pregnancy-related and pathological hypertrophy share reduced expression of the Kv4.3 channel.
  • Increased estrogen levels in late pregnancy may downregulate Kv4.3 protein and increase stretch-activated c-Src kinase activity.

Conclusions:

  • Cardiac adaptations during pregnancy involve specific molecular pathways distinct from pathological hypertrophy.
  • The Kv4.3 channel plays a crucial role in regulating cardiac structure during pregnancy.
  • Postpartum recovery involves the upregulation of cardioprotective natriuretic peptide and NO-cGMP signaling pathways.